News and Updates

Breakthrough T1D's new Medical Affairs unit will address the numerous challenges contributing to the slow adoption of groundbreaking T1D therapies.

Gerty Cori, Ph.D., Dorothy Crowfoot Hodgkin, FRS, and Rosalyn Yalow, Ph.D., won the Nobel Prize for diabetes discoveries.

Learn the basics about autoimmune disease, including prevalence in the U.S., possible causes, and why they are often called "invisible."

Dr. Cassandra Bazile is a scientist at Breakthrough T1D who champions community, mentorship, and inclusion in STEM.

Marjorie Lazarre has seen the life-changing outcomes of T1D research and is confident clinical trials are the path to cures.

DIAGNODE-3 is a phase 3 clinical trial of the disease-modifying therapy Diamyd® that aims to preserve insulin-producing beta cells.

Researchers are harnessing the power of stem cells to generate functional beta cells and islets, driving us closer toward type 1 diabetes cures.

The recipient of gene-edited islets to evade the immune system is making insulin without the use of immunusuppresives.

While we look back on 2024, we can reflect upon the incredible progress we’ve made in advancing breakthroughs toward cures and improving everyday life with T1D.   This wouldn’t have been possible without each and every one of you and your continued support of our mission as we drive toward cures for T1D.   Here are the […]

Meet Aiedan, a participant in the T1D RELAY clinical trial that aims to preserve insulin production in those newly diagnosed with type 1 diabetes.